Antioxidant Supplementation Combined with Tribulus Terrestris for Idiopathic Oligo-Asthenoteratozoospermia: A Pilot Prospective Study
Razi Medical Journal · 30.08.2026
DOI: 10.69667/rmj.26312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Razi Medical Journal, online erschienen am 05.08.2026. Verfasst von Mohammed Alnaqqah.
Abstract (Originalsprache)
Idiopathic oligo-asthenoteratozoospermia (OAT) causes a significant male infertility burden. Oxidative stress is a central pathogenic mechanism, making antioxidant supplementation a rational empirical intervention. The independent and combined contributions of individual antioxidants and herbal agents such as Tribulus terrestris remain insufficiently characterized in controlled clinical settings. This pilot study aimed to provide preliminary estimates of the effect size and variance of combined antioxidant and Tribulus terrestris supplementation (Tribonmix) on semen motility parameters in men with idiopathic OAT, and to generate the sample size data required for a future adequately powered randomized controlled trial (RCT). Thirty men with idiopathic OAT completed a prospective single-arm pilot study at a university-affiliated urology department in Libya (March–September 2025). All received Tribonmix twice daily for 3 months. Semen analysis was performed per WHO 2010 criteria before and after treatment. Paired t-tests were applied; 95% confidence intervals are reported for all mean differences. Active sperm motility at 30 minutes improved from 13.3% ± 6.5 to 17.4% ± 6.6 (mean difference +4.17%; 95% CI: +2.24 to +6.10%; p < 0.001). Dead spermatozoa at 30 minutes decreased from 63.4% ± 13.5 to 55.5% ± 15.0 (mean difference −7.97%; 95% CI: −12.6 to −3.4%; p = 0.002). No significant changes were observed in morphology, total count, or volume. The observed effect sizes provide preliminary variance estimates to power a future RCT requiring approximately 58–72 participants per arm. This pilot study provides preliminary evidence that combined antioxidant and Tribulus terrestris supplementation may improve sperm motility in men with idiopathic male subfertility and abnormal semen parameters. These findings are hypothesis-generating and should not be interpreted as definitive evidence of efficacy. A placebo-controlled RCT is warranted and now feasible to design using these variance estimates.
Zitieren
APA
Alnaqqah, M. (2026). Antioxidant Supplementation Combined with Tribulus Terrestris for Idiopathic Oligo-Asthenoteratozoospermia: A Pilot Prospective Study. Razi Medical Journal. https://doi.org/10.69667/rmj.26312
Vancouver
Alnaqqah M. Antioxidant Supplementation Combined with Tribulus Terrestris for Idiopathic Oligo-Asthenoteratozoospermia: A Pilot Prospective Study. Razi Medical Journal. 2026. doi:10.69667/rmj.26312
BibTeX
@article{Alnaqqah2026,
author = {Alnaqqah, Mohammed},
title = {Antioxidant Supplementation Combined with Tribulus Terrestris for Idiopathic Oligo-Asthenoteratozoospermia: A Pilot Prospective Study},
journal = {Razi Medical Journal},
year = {2026},
doi = {10.69667/rmj.26312}
}
EUVIMED